SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001509190-18-000034
Filing Date
2018-06-08
Accepted
2018-06-08 16:25:34
Documents
5
Effectiveness Date
2018-06-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A petx-20180608xdefa14a.htm DEFA14A 27527
2 GRAPHIC petx-20180608xdefa14ag001.jpg GRAPHIC 54608
3 GRAPHIC petx-20180608xdefa14ag002.jpg GRAPHIC 95972
4 GRAPHIC petx-20180608xdefa14ag003.jpg GRAPHIC 18878
5 GRAPHIC petx-20180608xdefa14ag004.jpg GRAPHIC 7899
  Complete submission text file 0001509190-18-000034.txt   273423
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35952 | Film No.: 18889812
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1